Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Day One Biopharmaceuticals, Inc. (DAWN)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 87,040,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company. Co. is engaged in developing and commercializing targeted therapies for patients with genomically-defined cancers. Co.'s main product candidate, DAY101 (tovorafenib), is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Co.'s second product candidate, pimasertib, is an oral, highly-selective small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK), a well-characterized key signaling node in the RAS/mitogen-activated protein kinase pathway.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 2,244,684 4,978,018
Total Buy Value $0 $0 $24,978,318 $65,978,328
Total People Bought 0 0 1 3
Total Buy Transactions 0 0 4 7
Total Shares Sold 225,453 235,538 246,104 4,525,329
Total Sell Value $3,837,225 $3,955,119 $4,100,690 $62,122,635
Total People Sold 4 4 4 8
Total Sell Transactions 14 18 25 103
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 174
  Page 4 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bender Jeremy Chief Executive Officer   •       •      –    2022-11-16 4 S $21.46 $32,469 D/D (1,513) 1,217,424     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2022-11-16 4 S $21.46 $8,090 D/D (377) 1,270,148     -
   York Charles N Ii COO, CFO and Secretary   •       –      –    2022-11-15 4 OE $0.00 $0 D/D 1,375 295,776     -
   Bender Jeremy Chief Executive Officer   •       •      –    2022-11-15 4 OE $0.00 $0 D/D 3,562 1,218,937     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2022-11-15 4 OE $0.00 $0 D/D 1,187 1,270,525     -
   Papanek Julie Director   –       •      –    2022-11-02 4 AS $20.01 $100,069 I/I (5,000) 419,358     -
   Bender Jeremy Chief Executive Officer   •       •      –    2022-11-01 4 AS $20.03 $250,355 D/D (12,500) 1,215,375     -
   Papanek Julie Director   –       •      –    2022-11-01 4 AS $20.04 $100,209 I/I (5,000) 424,358     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2022-11-01 4 AS $20.01 $200,050 D/D (10,000) 1,269,338     -
   York Charles N Ii COO, CFO and Secretary   •       –      –    2022-11-01 4 AS $20.03 $200,313 D/D (10,000) 294,401     -
   Papanek Julie Director   –       •      –    2022-10-04 4 AS $20.00 $100,000 I/I (5,000) 429,358     -
   Bender Jeremy Chief Executive Officer   •       •      –    2022-10-03 4 AS $20.05 $250,646 D/D (12,500) 1,227,875     -
   York Charles N Ii COO, CFO and Secretary   •       –      –    2022-10-03 4 AS $20.05 $200,473 D/D (10,000) 304,401     -
   Papanek Julie Director   –       •      –    2022-10-03 4 AS $20.06 $100,315 I/I (5,000) 434,358     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2022-10-03 4 AS $19.99 $199,852 D/D (10,000) 1,279,338     -
   Papanek Julie Director   –       •      –    2022-09-21 4 D $0.00 $0 I/I (1,500,000) 6,964,301     -
   Papanek Julie Director   –       •      –    2022-09-21 4 S $18.54 $11,380,779 I/I (613,603) 8,464,301     -
   Canaan Partners Xi Llc 10% Owner   –       –       •   2022-09-21 4 D $0.00 $0 D/D (1,500,000) 6,964,301     -
   Canaan Partners Xi Llc 10% Owner   –       –       •   2022-09-21 4 S $18.54 $11,380,779 D/D (613,603) 8,464,301     -
   Papanek Julie Director   –       •      –    2022-09-20 4 S $19.50 $2,900,425 I/I (148,670) 9,077,904     -
   Canaan Partners Xi Llc 10% Owner   –       –       •   2022-09-20 4 S $19.50 $2,900,425 D/D (148,670) 9,077,904     -
   Atlas Venture Fund Xi, L.p. 10% Owner   –       –       •   2022-09-19 4 AS $0.00 $0 D/D (600,854) 6,609,388     -
   Papanek Julie Director   –       •      –    2022-09-19 4 S $20.57 $1,578,233 I/I (76,725) 9,226,574     -
   Canaan Partners Xi Llc 10% Owner   –       –       •   2022-09-19 4 S $20.57 $1,578,233 D/D (76,725) 9,226,574     -
   Papanek Julie Director   –       •      –    2022-09-16 4 S $21.53 $2,484,458 I/I (115,307) 9,303,299     -
  174 Records found
  1  2  3  4  5  6  7   
  Page 4 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us